Hemorrhoids Clinical Trial
Official title:
A Comparative Clinical Research on Therapeutic Effect and Safety of Compound Carraghenates Cream Versus Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids
Verified date | February 2014 |
Source | Xian-Janssen Pharmaceutical Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Ethics Committee |
Study type | Interventional |
The purpose of this study is to compare the therapeutic effect and safety of compound carraghenates cream with Mayinglong musk hemorrhoid (swollen veins in the lower part of the rectum or anus) ointment in the treatment of hemorrhoids, especially regarding the relief of pain.
Status | Completed |
Enrollment | 123 |
Est. completion date | February 2008 |
Est. primary completion date | February 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 16 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Participants who agree to participate in the current study - Participants having painful hemorrhoids (swollen veins in the lower part of the rectum or anus [external hemorrhoid, mixed hemorrhoid, etc.]) - Participants who did not use other topical drugs to treat their hemorrhoids a day before the inclusion - Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period Exclusion Criteria: - Participants having other anorectal diseases , such as anal fistula , anal cleft , perianal abscess , and anorectal occupied lesions etc - Participants having hypersensitive predisposition or hypersensitive to any of components of the study drugs - Female participants under pregnancy or during breastfeeding period - Participants who fail to accept the scheduled visits or are lost to the visits - Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or mental disorders |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Xian-Janssen Pharmaceutical Ltd. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Acting Time | The time from the first administration of the drugs to the time when the participant feels that his (her) pain has been remitted remarkably will be assessed. | Day 1 up to Day 7 | No |
Primary | Pain Intensity Score at Day 4 | Pain intensity will be measured on an 11-point numeric rating scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates intense pain. Grade 1-4 represents mild pain, Grade 5-6 moderate pain, and Grade 7-10 serious pain. Higher score indicates worsening. | Day 4 | No |
Primary | Pain Intensity Score at Day 7 | Pain intensity will be measured on an 11-point numeric rating scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates intense pain. Grade 1-4 represents mild pain, Grade 5-6 moderate pain, and Grade 7-10 serious pain. Higher score indicates worsening. | Day 7 | No |
Primary | Daily Duration of Symptoms | The accumulated time of the onset of all symptoms in the same day will be assessed. The baseline value before the administration of the drugs is the accumulated time of the occurrence of all symptoms in the day prior to the visit. | Day 1 up to Day 7 | No |
Primary | Frequency of Defecation | The daily frequency of defecation for the day prior to the visit and each day during the trial period will be assessed. | Day 1 up to Day 7 | No |
Primary | Participants' Satisfaction for the Treatment | Participants' will assess for the treatment satisfaction on numeric rating scale (NRS) ranging from 1 to 5, where 1= Very unsatisfactory; 2= Unsatisfactory; 3=General; 4= Satisfactory; 5= Very satisfactory. | Day 7 | No |
Primary | Assessment of Other Symptoms and Signs Including Bleeding, Edema, Local Discomfort, and Prolapse | Participants will assess these symptoms on a score range of 0 to 3 where 0=none for all symptoms and 3= "Blood jets while defecating, and the blood jetting stops after defecation" for bleeding, "serious edema" for edema, "severe" for local discomfort and "it is difficult or unable to return the prolapsed pile" for prolapse. | Day 1 up to Day 7 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
Withdrawn |
NCT02851940 -
Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids
|
N/A | |
Recruiting |
NCT02301052 -
Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT02216305 -
HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial
|
N/A | |
Completed |
NCT02358174 -
Hemorrhoids and Metalloproteinases, Observational Study
|
N/A | |
Completed |
NCT01483833 -
Efficacy Study of Iferanserin to Treat Hemorrhoids
|
Phase 2 | |
Completed |
NCT00397137 -
Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids
|
N/A | |
Completed |
NCT00841620 -
Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids
|
Phase 4 | |
Completed |
NCT06459739 -
Effect of Sacral Erector Spinae Plane Block on Hemorrhoid and Pilonidal Sinus Surgery
|
N/A | |
Completed |
NCT04276298 -
Topical Analgesia Post-Haemorrhoidectomy
|
Phase 2/Phase 3 | |
Completed |
NCT04675177 -
Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05889962 -
Ultrasound-guided Pudendal Nerve Block for Pain After Hemorrhoidectomy
|
N/A | |
Recruiting |
NCT01961739 -
Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT02061176 -
THD Versus Open Haemorrhoidectomy
|
N/A | |
Withdrawn |
NCT00512044 -
Local Versus General Anaesthesia in Stapled Hemorrhoidectomy
|
Phase 4 | |
Completed |
NCT04031131 -
The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids
|
Phase 2 | |
Recruiting |
NCT04329364 -
RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty
|
Phase 2/Phase 3 | |
Completed |
NCT04567485 -
Impact of Moderate to Severe Pain in the Post-intervention Monitoring Room After Hemorrhoidectomy on the Length of Stay in the Outpatient Surgery Unit
|
||
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Completed |
NCT03298997 -
Ligation and Hemorrhoidopexy Technique Versus Ligation of Hemorrhoidal Arteries Using Ultrasound for Hemorrhoids
|
N/A |